- Home
- PGHL vs BRTX Comparison
PGHL vs BRTX Comparison
Compare PGHL & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- BRTX
- Stock Information
- Founded
- PGHL 2018
- BRTX 1997
- Country
- PGHL Hong Kong
- BRTX United States
- Employees
- PGHL N/A
- BRTX N/A
- Industry
- PGHL
- BRTX Managed Health Care
- Sector
- PGHL
- BRTX Health Care
- Exchange
- PGHL NYSE
- BRTX Nasdaq
- Market Cap
- PGHL 12.3M
- BRTX 12.2M
- IPO Year
- PGHL 2024
- BRTX N/A
- Fundamental
- Price
- PGHL $0.48
- BRTX $1.80
- Analyst Decision
- PGHL
- BRTX Strong Buy
- Analyst Count
- PGHL 0
- BRTX 1
- Target Price
- PGHL N/A
- BRTX $18.00
- AVG Volume (30 Days)
- PGHL 151.0K
- BRTX 22.7K
- Earning Date
- PGHL 05-21-2025
- BRTX 05-14-2025
- Dividend Yield
- PGHL N/A
- BRTX N/A
- EPS Growth
- PGHL N/A
- BRTX N/A
- EPS
- PGHL N/A
- BRTX N/A
- Revenue
- PGHL $17,166,534.00
- BRTX $401,000.00
- Revenue This Year
- PGHL N/A
- BRTX $446.88
- Revenue Next Year
- PGHL N/A
- BRTX $39.53
- P/E Ratio
- PGHL $13.74
- BRTX N/A
- Revenue Growth
- PGHL 56.11
- BRTX 175.03
- 52 Week Low
- PGHL $0.37
- BRTX $1.03
- 52 Week High
- PGHL $107.36
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- BRTX 52.33
- Support Level
- PGHL N/A
- BRTX $1.76
- Resistance Level
- PGHL N/A
- BRTX $1.84
- Average True Range (ATR)
- PGHL 0.00
- BRTX 0.07
- MACD
- PGHL 0.00
- BRTX 0.01
- Stochastic Oscillator
- PGHL 0.00
- BRTX 64.00
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.